Healthy Aging & Longevity
Tesamorelin / Ipamorelin
Pairs a clinically studied GHRH analog with a selective secretagogue for a broader growth hormone signal.
- Physician reviewed
- 503A pharmacy compounded
- Patient-specific prescription
Formats & pricing
- combination vial — reconstituted injectable$270
Pricing reflects the compounded preparation and physician review. Final therapy and dosing are determined only after your intake is reviewed.
Overview
What is Tesamorelin / Ipamorelin?
This combination brings together tesamorelin's GHRH receptor activity with ipamorelin's ghrelin receptor selectivity, addressing two distinct arms of growth hormone regulation in one prescription.
Mechanism
How it works
The two peptides act at different receptors, which practitioners describe as additive: one amplifies the releasing signal, the other the secretory pulse, with minimal impact on cortisol or prolactin.
Wellness support
Potential wellness support areas
These areas are commonly discussed within wellness-focused protocols. They are educational statements, not medical claims or guarantees of outcome.
- Explored for visceral fat and body composition
- Discussed for recovery and sleep depth
- Potential support for lean mass retention
- Monitored with IGF-1 and metabolic labs
Administration
Format & dosing
Nightly subcutaneous injection. Cycle length and dosing are determined by your physician following intake and lab review.
Labs & monitoring
Labs, testing & monitoring
Your physician determines the final testing requirements for Tesamorelin / Ipamorelin after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.
Bloodwork status
Baseline Labs Generally Required
Commonly reviewed at baseline
- IGF-1
- Comprehensive metabolic panel (CMP)
- Fasting glucose and A1c
- Lipid panel
- Thyroid panel (TSH, free T4)
Follow-up & monitoring
IGF-1 with fasting glucose and A1c at roughly 8 to 12 weeks, with dose adjustment based on the result.
Who may not be a candidate
- Pregnancy or nursing
- Active malignancy without oncology clearance
- Known hypersensitivity to the preparation
- Active pituitary disease
- Uncontrolled diabetes
Medication interactions
Your physician reviews all prescriptions, supplements, and over-the-counter medications during intake before anything is prescribed.
Safety
Safety & considerations
Compounded, not FDA-approved. Contraindicated with active malignancy. Glucose and IGF-1 monitoring generally advised.
Regulatory status: Compounded. Evidence level: Moderate. Eligibility, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed physician after review of your history.
Related therapies
Healthy Aging & Longevity
CJC-1295 / Ipamorelin
Growth hormone optimization for body composition and recovery.
Baseline Labs Generally Required
Healthy Aging & Longevity
Tesamorelin
Growth hormone-releasing peptide for visceral fat reduction.
Baseline Labs Generally Required
Healthy Aging & Longevity
MOTS-C
Mitochondrial-derived peptide for metabolic health and endurance.
Recent Labs Recommended
Physician reviewed
Every protocol is approved by a licensed physician.
503A compounded
Prepared by licensed US compounding pharmacies.
Patient-specific Rx
Prescriptions are issued in your name only.
No membership
No concierge fee and no subscription to browse or begin.